HeadSense Medical
12
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
16.7%
2 terminated/withdrawn out of 12 trials
60.0%
-26.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Indirect Intracranial Pressure Measurement in Patients With Suspected or Documented Concussion
Role: lead
An Evaluation of Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm
Role: lead
Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement
Role: lead
An Evaluation of a Non-invasive Brain Monitor
Role: lead
An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring Device
Role: lead
An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Routine Care
Role: lead
Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients
Role: lead
An Evaluation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion
Role: lead
An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm
Role: lead
Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP Monitoring
Role: lead
Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device
Role: lead
An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an External Ventricular Drainage (EVD) Device
Role: lead
All 12 trials loaded